These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 28894229)
1. VEGF expression correlates with neuronal differentiation and predicts a favorable prognosis in patients with neuroblastoma. Weng WC; Lin KH; Wu PY; Ho YH; Liu YL; Wang BJ; Chen CC; Lin YC; Liao YF; Lee WT; Hsu WM; Lee H Sci Rep; 2017 Sep; 7(1):11212. PubMed ID: 28894229 [TBL] [Abstract][Full Text] [Related]
2. Calreticulin Regulates VEGF-A in Neuroblastoma Cells. Weng WC; Lin KH; Wu PY; Lu YC; Weng YC; Wang BJ; Liao YF; Hsu WM; Lee WT; Lee H Mol Neurobiol; 2015 Aug; 52(1):758-70. PubMed ID: 25288151 [TBL] [Abstract][Full Text] [Related]
3. Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma. Chang HH; Lee H; Hu MK; Tsao PN; Juan HF; Huang MC; Shih YY; Wang BJ; Jeng YM; Chang CL; Huang SF; Tsay YG; Hsieh FJ; Lin KH; Hsu WM; Liao YF Clin Cancer Res; 2010 Sep; 16(17):4411-20. PubMed ID: 20736329 [TBL] [Abstract][Full Text] [Related]
4. Calreticulin expression in neuroblastoma--a novel independent prognostic factor. Hsu WM; Hsieh FJ; Jeng YM; Kuo ML; Chen CN; Lai DM; Hsieh LJ; Wang BT; Tsao PN; Lee H; Lin MT; Lai HS; Chen WJ Ann Oncol; 2005 Feb; 16(2):314-21. PubMed ID: 15668290 [TBL] [Abstract][Full Text] [Related]
5. Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma. Lee AC; Shih YY; Zhou F; Chao TC; Lee H; Liao YF; Hsu WM; Hong JH J Mol Med (Berl); 2019 Mar; 97(3):325-339. PubMed ID: 30612140 [TBL] [Abstract][Full Text] [Related]
6. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth. Streck CJ; Zhang Y; Zhou J; Ng C; Nathwani AC; Davidoff AM J Pediatr Surg; 2005 Jan; 40(1):236-43. PubMed ID: 15868591 [TBL] [Abstract][Full Text] [Related]
7. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms. Zins K; Kovatchki D; Lucas T; Abraham D Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669225 [TBL] [Abstract][Full Text] [Related]
8. Establishment of a neuroblastoma mouse model by subcutaneous xenograft transplantation and its use to study metastatic neuroblastoma. Gao Q; Chen CF; Dong Q; Hou L; Chen X; Zhi YL; Li X; Lu HT; Zhang HY Genet Mol Res; 2015 Dec; 14(4):16297-307. PubMed ID: 26662423 [TBL] [Abstract][Full Text] [Related]
9. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation. Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286 [TBL] [Abstract][Full Text] [Related]
10. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur GM; Himelstein BP Clin Cancer Res; 2000 May; 6(5):1900-8. PubMed ID: 10815914 [TBL] [Abstract][Full Text] [Related]
11. GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma. Ho WL; Chou CH; Jeng YM; Lu MY; Yang YL; Jou ST; Lin DT; Chang HH; Lin KH; Hsu WM; Huang MC Oncotarget; 2014 Dec; 5(23):12247-59. PubMed ID: 25362349 [TBL] [Abstract][Full Text] [Related]
12. Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts. Liu S; Tian Y; Chlenski A; Yang Q; Zage P; Salwen HR; Crawford SE; Cohn SL Am J Pathol; 2005 Mar; 166(3):891-900. PubMed ID: 15743800 [TBL] [Abstract][Full Text] [Related]
13. Expression of Ki-67, p53 and VEGF in pediatric neuroblastoma. Gheytanchi E; Mehrazma M; Madjd Z Asian Pac J Cancer Prev; 2014; 15(7):3065-70. PubMed ID: 24815448 [TBL] [Abstract][Full Text] [Related]
14. Dzieran J; Rodriguez Garcia A; Westermark UK; Henley AB; Eyre Sánchez E; Träger C; Johansson HJ; Lehtiö J; Arsenian-Henriksson M Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1229-E1238. PubMed ID: 29374092 [TBL] [Abstract][Full Text] [Related]
15. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer. Xiong J; Yang Q; Li J; Zhou S Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365 [TBL] [Abstract][Full Text] [Related]
16. The anti-VEGF antibody bevacizumab potently reduces the growth rate of high-risk neuroblastoma xenografts. Segerström L; Fuchs D; Bäckman U; Holmquist K; Christofferson R; Azarbayjani F Pediatr Res; 2006 Nov; 60(5):576-81. PubMed ID: 16988184 [TBL] [Abstract][Full Text] [Related]
17. The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma. Amoroso F; Capece M; Rotondo A; Cangelosi D; Ferracin M; Franceschini A; Raffaghello L; Pistoia V; Varesio L; Adinolfi E Oncogene; 2015 Oct; 34(41):5240-51. PubMed ID: 25619831 [TBL] [Abstract][Full Text] [Related]
18. Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer. Chen CN; Chang CC; Su TE; Hsu WM; Jeng YM; Ho MC; Hsieh FJ; Lee PH; Kuo ML; Lee H; Chang KJ Ann Surg Oncol; 2009 Feb; 16(2):524-33. PubMed ID: 19050968 [TBL] [Abstract][Full Text] [Related]
19. SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR‑410 in human neuroblastoma cells. Boyineni J; Tanpure S; Gnanamony M; Antony R; Fernández KS; Lin J; Pinson D; Gondi CS Int J Oncol; 2016 Oct; 49(4):1394-406. PubMed ID: 27498840 [TBL] [Abstract][Full Text] [Related]
20. Calreticulin regulates vascular endothelial growth factor-A mRNA stability in gastric cancer cells. Lee PC; Chiang JC; Chen CY; Chien YC; Chen WM; Huang CW; Weng WC; Chen CI; Lee PH; Chen CN; Lee H PLoS One; 2019; 14(11):e0225107. PubMed ID: 31725767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]